Press Releases Archives - Page 88 of 103 - Lupin

BSE 2296.10 NSE 2296.10

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2296.10 NSE 2296.10

Lupin Settles all Ongoing Litigation with Sunovion over Generic of LUNESTA® (eszopiclone)

January 3, 2011

Lupin Announces Litigation Settlement with Forest for Memantine Tablets

November 2, 2010

Lupin Announces Final FDA Approval for Suprax® (Cefixime) Chewable Tablets

November 2, 2010

Lupin Net Profit up by 34 % in Q2, FY 2010-11 Robust Growth, Strong Profits

November 1, 2010

Lupin announces settlement with Warner Chilcott of Loestrin® 24 Fe and Femcon® Fe Patent Litigations

October 14, 2010

Lupin Announces Final FDA Approval of Generic Hyzaar® and Cozaar®

October 4, 2010

Lupin appoints Paul McGarty as President for Lupin Pharmaceuticals Inc.

Lupin Net Profit up by 40 % in Q1, FY 2010-11 Consistent Growth, Strong Profits

Lupin receives FDA approval for Famotidine for Oral Suspension

Lupin receives FDA approval for Lamotrigine tablets

1 2 … 87 88 89 … 102 103

Search

Hit enter to search or ESC to close